{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:08:07Z","timestamp":1778558887483,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jneuroim.2013.12.007","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T02:15:50Z","timestamp":1386814550000},"page":"92-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Killer immunoglobulin-like receptor and their HLA ligands in Guillain\u2013Barr\u00e9 Syndrome"],"prefix":"10.1016","volume":"267","author":[{"given":"Stefan","family":"Blum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Csurhes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-3350","authenticated-orcid":false,"given":"Stephen","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Spies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"McCombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.12.007_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain\u2013Barre; syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol."},{"issue":"Suppl.","key":"10.1016\/j.jneuroim.2013.12.007_bb0015","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine"},{"issue":"Oct 31","key":"10.1016\/j.jneuroim.2013.12.007_bb9000","article-title":"Clinical features of patients with Guillain-Barre syndrome at seven hospitals on the East Coast of Australia","author":"Blum","year":"2013","journal-title":"J Peripher Nerv Syst."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03424.x","article-title":"Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease","volume":"149","author":"Boyton","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0030","series-title":"The KIR Gene Cluster","author":"Carrington","year":"2009"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","article-title":"Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain\u2013Barre syndrome","volume":"192","author":"Chi","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jocn.2004.04.006","article-title":"Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain\u2013Barr\u00e9 syndrome","volume":"12","author":"Csurhes","year":"2005","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0045","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","article-title":"T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"76","author":"Csurhes","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.jneuroim.2013.12.007_bb0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jneuroim.2010.08.004","article-title":"KIRs and their HLA ligands in remitting\u2013relapsing Multiple Sclerosis","volume":"229","author":"Fusco","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","article-title":"HLA class II alleles are not a general susceptibility factor in Guillain\u2013Barre syndrome","volume":"64","author":"Geleijns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(83)90058-9","article-title":"HLA-DR antigens in Mexican patients with Guillain\u2013Barre syndrome","volume":"4","author":"Gorodezky","year":"1983","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11882-011-0190-y","article-title":"Guillain\u2013Barr\u00e9 syndrome: modern theories of etiology","volume":"11","author":"Hardy","year":"2011","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0070","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","article-title":"Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain\u2013Barr\u00e9 syndrome patients compared to controls","volume":"15","author":"Harness","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00251-009-0396-5","article-title":"Susceptibility to Crohn's disease is mediated by KIR2DL2\/KIR2DL3 heterozygosity and the HLA-C ligand","volume":"61","author":"Hollenbach","year":"2009","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0080","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0085","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.4049\/jimmunol.169.5.2781","article-title":"Activation of APCs through CD40 or Toll-like receptor 9 Overcomes tolerance and precipitates autoimmune disease","volume":"169","author":"Ichikawa","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0090","article-title":"KIR\/HLA interactions and pathogen immunity","volume":"2011","author":"Jamil","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10875-008-9183-6","article-title":"Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease","volume":"28","author":"Jiao","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2005.08.008","article-title":"NK cells: elusive players in autoimmunity","volume":"26","author":"Johansson","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0165-5728(98)00072-1","article-title":"Guillain\u2013Barre and Fisher's syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies","volume":"88","author":"Koga","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.2008.156463","article-title":"Recurrent Guillain Barre syndrome","volume":"80","author":"Kuitwaard","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.smim.2008.06.003","article-title":"The Yin and Yang of HLA and KIR in human disease","volume":"20","author":"Kulkarni","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0120","first-page":"429","article-title":"HLA alleles in patients with Guillain\u2013Barre syndrome","volume":"113","author":"Li","year":"2000","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2006.07.017","article-title":"Studies of HLA associations in male and female patients with Guillain\u2013Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"180","author":"McCombe","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2009.03208.x","article-title":"The extensive polymorphism of KIR genes","volume":"129","author":"Middleton","year":"2010","journal-title":"Immunology"},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2013.12.007_bb0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-0039.2006.762_6.x","article-title":"KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma","volume":"69","author":"Pellett","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0145","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1212\/WNL.45.7.1419-a","article-title":"HLA antigens in severe forms of Guillain\u2013Barre syndrome","volume":"45","author":"Piradov","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-61779-842-9_23","article-title":"Overview of the killer cell immunoglobulin-like receptor system","volume":"882","author":"Rajalingam","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky's postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0160","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0165","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1586\/erv.10.132","article-title":"Cytolytic CD4(+) T cells in viral immunity","volume":"9","author":"Soghoian","year":"2010","journal-title":"Exp. Rev. Vaccin."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.177.1.155","volume":"177","author":"Takeda","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0175","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.4049\/jimmunol.173.11.6719","article-title":"Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors","volume":"173","author":"van Bergen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0180","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain\u2013Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/mp.54.6.381","article-title":"Guillain Barre syndrome","volume":"54","author":"Winer","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jneuroim.2005.02.011","article-title":"Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis","volume":"163","author":"Xu","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-510X(98)00065-3","article-title":"Natural killer cells in patients with Guillain\u2013Barre syndrome","volume":"157","author":"Yoshii","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.molimm.2004.07.025","article-title":"NK cell regulation of T cell-mediated responses","volume":"42","author":"Zingoni","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.007_bb0210","first-page":"408","article-title":"NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses","volume":"3","author":"Zingoni","year":"2012","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281300338X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281300338X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:22:18Z","timestamp":1759047738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281300338X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S016557281300338X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.12.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Killer immunoglobulin-like receptor and their HLA ligands in Guillain\u2013Barr\u00e9 Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}